BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  FDA Approves OncoVista Innovative Therapies, Inc.'s Phase I Clinical Trial of New Drug Candidate (OVI-117) for Solid Tumors

  July 10, 2012

   · 

  1 min read
• Drug Development

  Ohr Pharmaceutical Announces Positive Preclinical Safety Study Results for Squalamine Eye Drop for Wet-AMD

  July 10, 2012

   · 

  6 min read
• ImmuPharma plc on TheBioTechPanel-TV.com

  July 10, 2012

   · 

  1 min read
• Business

  BioNeutral Appoints Mr. Mark Lowenthal as Chief Executive and President

  July 10, 2012

   · 

  3 min read
• Genetown

  Synageva BioPharma Announces $80 Million Proposed Public Offering of Common Stock

  July 10, 2012

   · 

  1 min read
• BioMidwest

  Terumo BCT Launches Mononuclear Cell Collection Protocol for Spectra Optia® Apheresis System in the United States

  July 10, 2012

   · 

  1 min read
• FDA

  Oculus Innovative Sciences, Inc. Receives Chinese SFDA Regulatory Approval of Microcyn(R) Hydrogel

  July 10, 2012

   · 

  1 min read
• Drug Development

  Eisai Inc.'s Halavan Misses Endpoints in Phase III Trial

  July 10, 2012

   · 

  6 min read
• FDA

  Integrity Life Sciences Receives FDA 510(k) Clearance for its Integrity Spinal Care System Medical Device

  July 10, 2012

   · 

  3 min read
• Business

  Discovery Laboratories to Report Second Quarter 2012 Results and Hold Conference Call on Thursday, August 2, 2012

  July 10, 2012

   · 

  1 min read